Similar articles

• Response rates to a staged antibiotic regimen in febrile neutropenic patients.

  Barnes RA, Rogers TR. Barnes RA, et al. J Antimicrob Chemother. 1988 Nov;22(5):759-63. doi: 10.1093/jac/22.5.759. J Antimicrob Chemother. 1988. PMID: 3209532
• Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview.

  Lieschke GJ, Bell D, Rawlinson W, Green MD, Sheridan W, Morstyn G, Stuart-Harris R, Kefford RF, Levi J, Sorrell T, et al. Lieschke GJ, et al. Eur J Cancer Clin Oncol. 1989;25 Suppl 2:S37-42. Eur J Cancer Clin Oncol. 1989. PMID: 2693108 Review.
• European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.

  Croydon E, Weerts D. Croydon E, et al. Chemioterapia. 1987 Jun;6(2 Suppl):405-7. Chemioterapia. 1987. PMID: 3334585 Clinical Trial. No abstract available.
• [Management of the neutropenic and febrile immunocompromised host].

  Barsanti AC, Tartas N. Barsanti AC, et al. Medicina (B Aires). 1988;48(6):679-94. Medicina (B Aires). 1988. PMID: 2687617 Review. Spanish. No abstract available.
• Role of antimicrobial combinations in the therapy of infections in neutropenic patients.

  Gialdroni Grassi G, Grassi C. Gialdroni Grassi G, et al. Chemioterapia. 1987 Jun;6(2 Suppl):398-400. Chemioterapia. 1987. PMID: 3334582 Review. No abstract available.